1st Quarter - Report

CROSSROADS STRATEGIES, LLC for INDIVIOR INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to overdose reversal products including Naloxone; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4); FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1968 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.